Cargando…

Hypoxia Activates Src and Promotes Endocytosis Which Decreases MMP-2 Activity and Aggravates Renal Interstitial Fibrosis

The aggravation of renal interstitial fibrosis in the advanced-stage of chronic kidney disease is related to decreased matrix metalloproteinase-2 (MMP-2) activity, which is induced by hypoxia in the kidney; however, the specific mechanism remains unclear. We previously demonstrated that inhibition o...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Zhengyuan, Liu, Lei, Wang, Zhi, Cai, Yingying, Xu, Qing, Chen, Pingsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855803/
https://www.ncbi.nlm.nih.gov/pubmed/29462885
http://dx.doi.org/10.3390/ijms19020581
_version_ 1783307182561820672
author Cheng, Zhengyuan
Liu, Lei
Wang, Zhi
Cai, Yingying
Xu, Qing
Chen, Pingsheng
author_facet Cheng, Zhengyuan
Liu, Lei
Wang, Zhi
Cai, Yingying
Xu, Qing
Chen, Pingsheng
author_sort Cheng, Zhengyuan
collection PubMed
description The aggravation of renal interstitial fibrosis in the advanced-stage of chronic kidney disease is related to decreased matrix metalloproteinase-2 (MMP-2) activity, which is induced by hypoxia in the kidney; however, the specific mechanism remains unclear. We previously demonstrated that inhibition of Caveolin-1, a key gene involved in endocytosis, increased MMP-2 activity in hypoxic HK-2 cells. It has been reported that activated Src (phospho-Src Tyr416) is a key molecule in multiple fibrotic pathways. However, whether Src functions on the regulation of Caveolin-1 and MMP-2 activity in hypoxic HK-2 cells remains poorly understood. To explore the underlying mechanism, a rat model of renal interstitial fibrosis was established, then we observed obvious hypoxia in fibrotic kidney tissue and the protein levels of phospho-Src and Caveolin-1 increased, while MMP-2 activity decreased. Next, we treated HK-2 cells with the phospho-Src inhibitor PP1. Compared with normal cells grown in hypoxia, in cells treated with PP1, the protein levels of phospho-Src and Caveolin-1 decreased, as did the protein levels of the MMP-2-activity-regulated molecules RECK (reversion-inducing-cysteine-rich protein with kazal motifs) and TIMP-2 (tissue inhibitor of metalloproteinase-2), while the protein level of MT1-MMP (membrane type 1-matrix metalloproteinase) increased and MMP-2 activity was enhanced. Therefore, hypoxia promotes the phosphorylation of Src and phospho-Src can enhance the endocytosis of HK-2 cells, which leads to decreased MMP-2 activity and aggravates renal interstitial fibrosis.
format Online
Article
Text
id pubmed-5855803
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-58558032018-03-20 Hypoxia Activates Src and Promotes Endocytosis Which Decreases MMP-2 Activity and Aggravates Renal Interstitial Fibrosis Cheng, Zhengyuan Liu, Lei Wang, Zhi Cai, Yingying Xu, Qing Chen, Pingsheng Int J Mol Sci Article The aggravation of renal interstitial fibrosis in the advanced-stage of chronic kidney disease is related to decreased matrix metalloproteinase-2 (MMP-2) activity, which is induced by hypoxia in the kidney; however, the specific mechanism remains unclear. We previously demonstrated that inhibition of Caveolin-1, a key gene involved in endocytosis, increased MMP-2 activity in hypoxic HK-2 cells. It has been reported that activated Src (phospho-Src Tyr416) is a key molecule in multiple fibrotic pathways. However, whether Src functions on the regulation of Caveolin-1 and MMP-2 activity in hypoxic HK-2 cells remains poorly understood. To explore the underlying mechanism, a rat model of renal interstitial fibrosis was established, then we observed obvious hypoxia in fibrotic kidney tissue and the protein levels of phospho-Src and Caveolin-1 increased, while MMP-2 activity decreased. Next, we treated HK-2 cells with the phospho-Src inhibitor PP1. Compared with normal cells grown in hypoxia, in cells treated with PP1, the protein levels of phospho-Src and Caveolin-1 decreased, as did the protein levels of the MMP-2-activity-regulated molecules RECK (reversion-inducing-cysteine-rich protein with kazal motifs) and TIMP-2 (tissue inhibitor of metalloproteinase-2), while the protein level of MT1-MMP (membrane type 1-matrix metalloproteinase) increased and MMP-2 activity was enhanced. Therefore, hypoxia promotes the phosphorylation of Src and phospho-Src can enhance the endocytosis of HK-2 cells, which leads to decreased MMP-2 activity and aggravates renal interstitial fibrosis. MDPI 2018-02-15 /pmc/articles/PMC5855803/ /pubmed/29462885 http://dx.doi.org/10.3390/ijms19020581 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Cheng, Zhengyuan
Liu, Lei
Wang, Zhi
Cai, Yingying
Xu, Qing
Chen, Pingsheng
Hypoxia Activates Src and Promotes Endocytosis Which Decreases MMP-2 Activity and Aggravates Renal Interstitial Fibrosis
title Hypoxia Activates Src and Promotes Endocytosis Which Decreases MMP-2 Activity and Aggravates Renal Interstitial Fibrosis
title_full Hypoxia Activates Src and Promotes Endocytosis Which Decreases MMP-2 Activity and Aggravates Renal Interstitial Fibrosis
title_fullStr Hypoxia Activates Src and Promotes Endocytosis Which Decreases MMP-2 Activity and Aggravates Renal Interstitial Fibrosis
title_full_unstemmed Hypoxia Activates Src and Promotes Endocytosis Which Decreases MMP-2 Activity and Aggravates Renal Interstitial Fibrosis
title_short Hypoxia Activates Src and Promotes Endocytosis Which Decreases MMP-2 Activity and Aggravates Renal Interstitial Fibrosis
title_sort hypoxia activates src and promotes endocytosis which decreases mmp-2 activity and aggravates renal interstitial fibrosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855803/
https://www.ncbi.nlm.nih.gov/pubmed/29462885
http://dx.doi.org/10.3390/ijms19020581
work_keys_str_mv AT chengzhengyuan hypoxiaactivatessrcandpromotesendocytosiswhichdecreasesmmp2activityandaggravatesrenalinterstitialfibrosis
AT liulei hypoxiaactivatessrcandpromotesendocytosiswhichdecreasesmmp2activityandaggravatesrenalinterstitialfibrosis
AT wangzhi hypoxiaactivatessrcandpromotesendocytosiswhichdecreasesmmp2activityandaggravatesrenalinterstitialfibrosis
AT caiyingying hypoxiaactivatessrcandpromotesendocytosiswhichdecreasesmmp2activityandaggravatesrenalinterstitialfibrosis
AT xuqing hypoxiaactivatessrcandpromotesendocytosiswhichdecreasesmmp2activityandaggravatesrenalinterstitialfibrosis
AT chenpingsheng hypoxiaactivatessrcandpromotesendocytosiswhichdecreasesmmp2activityandaggravatesrenalinterstitialfibrosis